182 related articles for article (PubMed ID: 21821500)
1. The effect of streptokinase therapy in STEMI and conventional therapy in NSTEMI patients on TIMI risk index, B-type natriuretic peptide and high-sensitive C-reactive protein.
Kurt IH; Batur MK; Unal I
Anadolu Kardiyol Derg; 2011 Sep; 11(6):530-5. PubMed ID: 21821500
[TBL] [Abstract][Full Text] [Related]
2. Changes in BNP, hs-CRP and TIMI risk index with addition of tirofiban during primary percutaneous coronary intervention for acute STEMI: a prospective observational cohort study.
Kurt IH; Demirkol S; Ünal I; Batur MK
Anadolu Kardiyol Derg; 2012 Mar; 12(2):107-14. PubMed ID: 22281789
[TBL] [Abstract][Full Text] [Related]
3. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
[TBL] [Abstract][Full Text] [Related]
4. Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.
Jarai R; Huber K; Bogaerts K; Droogne W; Ezekowitz J; Granger CB; Sinnaeve PR; Ross AM; Zeymer U; Armstrong PW; Van de Werf FJ;
Am Heart J; 2010 Jan; 159(1):131-40. PubMed ID: 20102879
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score.
Kuklinska AM; Sobkowicz B; Mroczko B; Sawicki R; Musial WJ; Knapp M; Dobrzycki S; Szmitkowski M
Clin Chim Acta; 2007 Jul; 382(1-2):106-11. PubMed ID: 17482153
[TBL] [Abstract][Full Text] [Related]
6. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
[TBL] [Abstract][Full Text] [Related]
7. The significance of circulating levels of both cardiac troponin I and high-sensitivity C reactive protein for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarction.
Foussas SG; Zairis MN; Makrygiannis SS; Manousakis SJ; Anastassiadis FA; Apostolatos CS; Patsourakos NG; Glyptis MP; Papadopoulos JK; Xenos DC; Adamopoulou EN; Olympios CD; Argyrakis SK
Heart; 2007 Aug; 93(8):952-6. PubMed ID: 17344331
[TBL] [Abstract][Full Text] [Related]
8. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.
Foussas SG; Zairis MN; Lyras AG; Patsourakos NG; Tsirimpis VG; Katsaros K; Beldekos DJ; Handanis SM; Mytas DZ; Karidis KS; Tselioti PG; Prekates AA; Ambrose JA
Am J Cardiol; 2005 Aug; 96(4):533-7. PubMed ID: 16098307
[TBL] [Abstract][Full Text] [Related]
9. The influence of thrombolytic therapy on C-reactive protein in ST-segment elevation acute myocardial infarction.
Tsakiris AK; Marnelos PG; Nearchou NS; Papadakis JE; Karatzis EN; Skoufas PD
Hellenic J Cardiol; 2006; 47(4):218-22. PubMed ID: 16897925
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein on admission and the success of thrombolytic therapy with streptokinase: is there any relation?
Amasyali B; Kose S; Kilic A; Iyisoy A; Barcin C; Kursaklioglu H; Barindik N; Tokgoz S; Isik E; Demirtas E
Int J Cardiol; 2003 Nov; 92(1):27-33. PubMed ID: 14602213
[TBL] [Abstract][Full Text] [Related]
11. Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty.
Grabowski M; Filipiak KJ; Karpinski G; Wretowski D; Rdzanek A; Huczek Z; Horszczaruk GJ; Kochman J; Rudowski R; Opolski G
Am Heart J; 2004 Oct; 148(4):655-62. PubMed ID: 15459597
[TBL] [Abstract][Full Text] [Related]
12. Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction.
Jeong YH; Kim WJ; Park DW; Choi BR; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ
Int J Cardiol; 2010 May; 141(2):175-81. PubMed ID: 19144424
[TBL] [Abstract][Full Text] [Related]
13. Application of the Thrombolysis in Myocardial Infarction risk index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction.
Wiviott SD; Morrow DA; Frederick PD; Antman EM; Braunwald E;
J Am Coll Cardiol; 2006 Apr; 47(8):1553-8. PubMed ID: 16630990
[TBL] [Abstract][Full Text] [Related]
14. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
[TBL] [Abstract][Full Text] [Related]
15. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty.
Grabowski M; Filipiak KJ; Malek LA; Karpinski G; Huczek Z; Stolarz P; Spiewak M; Kochman J; Rudowski R; Opolski G
Int J Cardiol; 2007 Feb; 115(3):386-90. PubMed ID: 16860415
[TBL] [Abstract][Full Text] [Related]
16. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M
Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130
[TBL] [Abstract][Full Text] [Related]
17. The course of D-dimer, high-sensitivity C-reactive protein and pro-B-type natriuretic peptide in patients with non-ST-elevation myocardial infarction.
Ghanavatian S; Stein RA; Atar D; Hole L; Agewall S
Clin Lab; 2011; 57(9-10):771-6. PubMed ID: 22029194
[TBL] [Abstract][Full Text] [Related]
18. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction.
Sadanandan S; Cannon CP; Chekuri K; Murphy SA; Dibattiste PM; Morrow DA; de Lemos JA; Braunwald E; Gibson CM
J Am Coll Cardiol; 2004 Aug; 44(3):564-8. PubMed ID: 15358021
[TBL] [Abstract][Full Text] [Related]
19. Comparison of angiographic and other findings and mortality in non-ST-segment elevation versus ST-segment elevation myocardial infarction in patients undergoing early invasive intervention.
Song YB; Hahn JY; Kim JH; Lee SY; Choi SH; Choi JH; Choi SH; Lee SH; Yoon J; Kim YJ; Jeong MH; Gwon HC;
Am J Cardiol; 2010 Nov; 106(10):1397-403. PubMed ID: 21059427
[TBL] [Abstract][Full Text] [Related]
20. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
